Alectinib Versus Crizotinib in Asian Patients With Treatment-Naïve Advanced ALK-Positive NSCLC: Five-Year Update From the Phase 3 ALESIA Study
| Autor: | Zhou, Caicun, Lu, You, Kim, Sang-We, Reungwetwattana, Thanyanan, Zhou, Jianying, Zhang, Yiping, He, Jianxing, Yang, Jin-Ji, Cheng, Ying, Lee, Se-Hoon, Chang, Jianhua, Fang, Jian, Liu, Zhe, Bu, Lilian, Qian, Li, Xu, Tingting, Archer, Venice, Hilton, Magalie, Zhou, Mingzhu, Zhang, Li |
|---|---|
| Zdroj: | In JTO Clinical and Research Reports September 2024 5(9) |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|